Prodigiosin isolated from Hahella chejuensis suppresses lipopolysaccharide-induced NO production by inhibiting p38 MAPK, JNK and NF-κB activation in murine peritoneal macrophages

International Immunopharmacology

Volumn 7, Issue 13, 2007, Pages 1825-1833

  Huh, Jung Eun ^a   Yim, Joung Han ^b   Lee, Hong Kum ^b   Moon, Eun Yi ^c   Rhee, Dong Kwon ^a   Pyo, Suhkneung ^a  

^a Sungkyunkwan University   (South Korea)

^b Korea Research Institute of Ships and Ocean Engineering   (South Korea)

^c Sejong University   (South Korea)

Author keywords

Hahella chejuensis; Macrophages; MAPK; NF kB; Nitric oxide; Prodigiosin

Indexed keywords

CYTOKINE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PRODIGIOSIN; STRESS ACTIVATED PROTEIN KINASE; THIOGLYCOLIC ACID; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENETIC TRANSCRIPTION; HAHELLA CHEJUENSIS; IMMUNOSUPPRESSIVE TREATMENT; MACROPHAGE; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; CYTOKINES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PRODIGIOSIN; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1; WATER MICROBIOLOGY;

EID: 35748967869     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.09.002     Document Type: Article

References (42)

1. Jeong H., Yim J.H., Lee C., Choi S.H., Park Y.K., Yoon S.H., et al. Genomic blueprint of Hahella chejuensis, a marine microbe producing an algicidal agent. Nucleic Acids Res 33 22 (2005) 7066-7073
2. Lee H.K., Chun J., Moon E.Y., Ko S.H., Lee D.S., Lee H.S., et al. Hahella chejuensis gen. nov., sp. nov., an extracellular-polysaccharide-producing marine bacterium. Int J Syst Evol Microbiol 51 Pt 2 (2001) 661-666
3. + ATPase, inhibits vacuolar acidification and affects glycoprotein processing. FEBS Lett 359 1 (1995) 153-159
4. Songia S., Mortellaro A., Taverna S., Fornasiero C., Scheiber E.A., Erba F., et al. Characterisation of the new immunosuppressive drug undecylprodigiosin in human lymphocytes. J Immunol 158 (1997) 3987-3995
5. Pandeya R., Chanderb R., and Sainisa K.B. A novel prodigiosin-like immunosuppressant from an alkalophilic Micrococcus sp. Int Immunopharmacol 3 2 (2003) 159-167
6. Hahn H., and Kaufmann S.H. The role of cell-mediated immunity in bacterial infections. Rev Infect Dis 3 (1981) 1221-1250
7. Verstovsek S., Maccubbin D., and Mihich E. Tumoricidal activation of murine resident peritoneal macrohages by interleukin 2 and tumor necrosis factor. Cancer Res 52 (1992) 3880-3885
8. Dullens H.F., De Weger R.A., Van Der Maas M., Den Besten P.J., Vandebriel R.J., and Den Otter W. Production of specific macrophage-arming factor precedes cytotoxic T lymphocyte activity in vivo during tumor rejection. Cancer Immunol Immunother 30 1 (1989) 28-33
9. Gautam S., and Deodhar S. Generation of tumoricidal effector cells by human C-reactive protein and muramyl tripeptide: a comparative study. J Biol Response Modif 8 5 (1989) 560-569
10. Paulnock D.M., and Lambert L.E. Identification and characterization of monoclonal antibodies specific for macrophages at intermediate stages in the tumoricidal activation pathway. J Immunol 144 (1990) 765-773
11. Arden L., Lansdorp P., and De Groot E. A growth factor for B cell hybridomas produced by human monocytes. Lymphokines 10 (1985) 175-185
12. Arenzana-Seisdedos F., and Virelizier J. Interferons as macrophage-activating factors. II. Enhanced secretion of interleukin 1 by lipopolysaccharide-stimulated human monocytes. Eur J Immunol 13 (1983) 437-440
13. Chokri M., Freudenberg M., Galanos C., Poindron P., and Bartholeyns J. Antitumoral effects of lipopolysacchride, tumor necrosis factor, interferon and activated macrophages: synergism and tissue distribution. Anticancer Res 9 (1989) 1185-1190
14. Stuehr D.J., and Marletta M.A. Synthesis of nitrite and nitrate in macrophage cell lines. Cancer Res 47 (1987) 5590-5594
15. Keller R., Keist R., and Frei K. Lymphokines and bacteria that induce tumoricidal activity, trigger a different secretory response in macrophages. Eur J Immunol 20 (1990) 695-698
16. Feldmann M., Brennan F.M., and Maini R. Cytokines in autoimmune disorders. Int Rev Immunol 17 (1998) 217-228
17. O'Shea J.J., Ma A., and Lipsky P. Cytokines and autoimmunity. Nat Rev Immunol 2 (2002) 37-45
18. Wright S.D., Ramons R.A., Tobias P.S., Ulevitch R.J., and Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249 (1990) 1431-1433
19. Dong Z., O'Brian C.A., and Fidler I.J. Activation of tumoricidal properties in macrophages by lipopolysaccharide requires protein tyrosine kinase activity. J Leukoc Biol 53 (1993) 53-60
20. Um S.H., Rhee D.K., and Pyo S. Involvement of protein kinase C and tyrosine kinase in tumoricidal activation of macrophage induced by Streptococcus pneumoniae type II capsular polysaccharide. Int Immunopharcol 2 (2002) 129-137
21. Jaramillo M., Naccache P.H., and Olivier M. Monosodium urate crystals synergize with IFN-gamma to generate macrophage nitric oxide: involvement of extracellular signal-regulated kinase 1/2 and NF-kappa B. J Immunol 172 (2004) 5734-5742
22. Guha M., and Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 13 (2001) 85-94
23. Caamano J., and Hunter C.A. NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions. Clin Microbiol Rev 15 (2002) 414-429
24. Schorey J.S., and Cooper A.M. Macrophage signalling upon mycobacterial infection: the MAP kinases lead the way. Cell Microbiol 5 (2003) 133-142
25. Heitmer M.R., Scarim A.L., and Corbett J.A. Double stranded RNA induced nitric oxide synthase expression and IL-1 release by murine macrophages requires NF-kappaB activation. J Biol Chem 273 (1998) 15301-15307
26. Carter A.B., Mocrick M.M., and Hunninghake G.W. Both Erk and p38 kinases are necessary for cytokine gene transcription. Am J Respir Cell Mol Biol 20 (1999) 751-758
27. Ajizian S.J., English B.K., and Meals E.A. Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma. J Infect Dis 179 (1999) 939-944
28. Scherle P.A., Jones E.A., Favata M.F., Daulerio A.J., Covington M.B., Nurnberg S.A., et al. Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytes. J Immunol 161 (1998) 5681-5686
29. Denizot F., and Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89 (1986) 271-277
30. Ding A.H., Nathan C.F., and Stuehr D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 141 (1988) 2407-2412
31. Cho S.J., Kang N.S., Park S.Y., Kim B.O., Rhee D.K., and Pyo S. Induction of apoptosis and expression of apoptosis related genes in human epithelial carcinoma cells by Helicobacter pylori VacA toxin. Toxicon 42 6 (2003) 601-611
32. Xie Q.W., Whisnant R., and Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon-γ and bacterial lipopolysaccharide. J Exp Med 177 (1993) 1779-1784
33. Nussler A.K., and Billiar T.R. Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukoc Biol 54 (1993) 171-178
34. Xie Q.W., Kashiwabara Y., and Nathan C. Role of transcription factor NF-kappaB/Rel in induction of nitric oxide synthase. J Biol Chem 269 (1994) 4705-4708
35. Bogdan C. Nitric oxide and the immune response. Nat Immunol 2 (2001) 907-916
36. Wu C.H., Chen T.L., Chen T.G., Ho W.P., Chiu W.T., and Chen R.M. Nitric oxide modulates pro- and anti-inflammatory cytokines in lipopolysaccharide-activated macrophages. J Trauma 55 3 (2003) 540-545
37. Xagorari A., Papapetropoulos A., Mauromatis A., Economou M., Fotsis T., and Roussos C. Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages. J Pharmacol Exp Ther 296 (2001) 181-187
38. Romics L., Kodys K., Dolganiuc A., Graham L., Velayudham A., Mandrekar P., and Szabo G. Diverse regulation of NF-kappaB and peroxisome proliferator-activated receptors in murine nonalcoholic fatty liver. Hepatology 40 (2004) 376-385
39. May M.J., and Ghosh S. Signal transduction through NF-kappaB. Immunol Today 19 (1998) 80-88
40. Carter A.B., Knudtson K.L., Monick M.M., and Hunninghake G.W. The p38 mitogen-activated protein kinase is required for NF-kappaB-dependent gene expression. The role of TATA-binding protein (TBP). J Biol Chem 274 (1999) 30858-30863
41. Ulevitch R.J., and Tobias P.S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 13 (1995) 437-457
42. Schumann R.R., Leong S.R., Flaggs G.W., Gray P.W., Wright S.D., Mathison J.C., Tobias P.S., and Ulevitch R.J. Structure and function of lipopolysaccharide binding protein. Science 249 (1990) 1429-1431